Figures & data
Table 1. Intraoperative variables
Table 2. Values of MAPFootnotea during surgery
Figure 1. Serum creatinine (SCr) (mg/dl), and creatinine clearance (CCr) (mL/min) through the observation period.
![Figure 1. Serum creatinine (SCr) (mg/dl), and creatinine clearance (CCr) (mL/min) through the observation period.](/cms/asset/e537934f-d0a8-4e87-b77b-5c796a91c18e/irnf_a_11379180_uf0001_b.gif)
Figure 3. Evolution of serum creatinine (SCr) along the observation period in patients with SCr at T4 less or equal to 2 mg/dl (Group I), or above 2 mg/dl (Group II). It is also shown FENa at the end of the study (T4).
![Figure 3. Evolution of serum creatinine (SCr) along the observation period in patients with SCr at T4 less or equal to 2 mg/dl (Group I), or above 2 mg/dl (Group II). It is also shown FENa at the end of the study (T4).](/cms/asset/ffbc44f6-a0e0-4b98-81af-b70171a8e0b7/irnf_a_11379180_uf0003_b.gif)
Figure 4. Evolution of serum creatinine (SCr) along the observation period in patients with SCr at T4 less or equal to 1.5 mg/dL, or above 1.5 mg/dL. It is also shown FENa at the end of the study (T4).
![Figure 4. Evolution of serum creatinine (SCr) along the observation period in patients with SCr at T4 less or equal to 1.5 mg/dL, or above 1.5 mg/dL. It is also shown FENa at the end of the study (T4).](/cms/asset/1169c28c-d1c1-44a1-b616-7e9bbe26c8dd/irnf_a_11379180_uf0004_b.gif)
Table 3. Results of univariate analysis. Only baseline SCr, FENa at T4, frusemide dose and hemodilution were statistically associated with groups
Table 4. In multivariate analysis, only baseline Scr and furosemide dose reached statistical significance